This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.
TREMFYA® (guselkumab)
Medical Information
TREMFYA - Home
Last updated: 11/07/2025
TREMFYA® (guselkumab)
One-Press
Patient-Controlled Injector
TREMFYA is approved for the treatment of:
- Adults and children 6 years of age and older who also weigh at least 88 pounds (40 kg) with moderate-to-severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light).
- Adults and children 6 years of age and older who also weigh at least 88 pounds (40 kg) with active psoriatic arthritis (PsA).
- Adults with moderately to severely active ulcerative colitis.
- Adults with moderately to severely active Crohn’s disease.
This information is in supplement to the medication guide and instructions for Use. Prior to injection, patients should be trained by their healthcare provider.
Overview
Important information about TREMFYA One-Press injector parts and storage conditions
Preparation
Summary of preparatory steps with regards to the supplies you will need and selecting an injection site before using TREMFYA One-Press injector
Injection
Stepwise illustration of using TREMFYA One-Press injector for administration
After injection
Recommendations for post-injection care and disposal
Download instructions
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.